封面
市场调查报告书
商品编码
1571467

非侵入性脑外伤监测设备市场规模、份额、趋势分析报告:按产品、最终用途、地区、细分市场预测,2024-2030 年

Non-invasive Brain Trauma Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Monitoring Devices, Consumables), By End-use (Neurological Centres), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

非侵入性脑外伤监测设备市场成长与趋势:

根据Grand View Research, Inc.的最新报告,预计到2030年,全球非侵入性脑外伤监测设备市场规模将达到248亿美元,2024年至2030年复合年增长率为8.6%。

创伤性脑损伤(TBI)的负担日益增加,是阿兹海默症和帕金森氏症等神经退化性疾病的主要原因。因此,人们做出了大量努力来提高地方和全球层面的认识,这提高了诊断率并主导了非侵入性脑外伤监测设备的成长。

该领域的技术进步,加上准确性、便携性和可负担性,支持了行业的成长。例如,最近可用的非侵入性颅内压监测仪,例如经颅都卜勒超音波(TCD),定位更精确,创建更好的压力梯度,并提供更高的治疗精度。

微创手术(MIS)对患者来说创伤较小,可以最大限度地减少併发症并加快康復速度。非侵入性脑外伤监测设备在微创神经外科中扮演重要角色。因此,MIS案例数量的增加正在推动产业的成长。

该行业的主要目标人群是60岁以上。该族群是 TBI 及其併发症的高危险群。世界老化人口不断增加,是该产业的关键驱动力。

非侵入性脑外伤监测设备市场报告亮点

  • 监测设备,包括颅内压监测仪、MRI扫描仪、CT扫描仪、PET扫描仪、脑电图和脑磁图,占据较大份额,2023年约63.2%。与该设备相关的高成本以及这些设备的使用量的增加主导了该细分市场的成长。
  • 预计该产品领域的消耗品子区隔将在预测期内呈现良好的成长。消耗品的重复购买和日常维护活动预计将刺激对这些产品的需求。
  • 根据最终用途,市场分为医院、神经中心和其他环境。以最终用途计算,医院占销售额的80.9%以上。医院进行的大量手术推动了这一增长。
  • 2023 年,北美将主导非侵入性脑外伤监测设备市场。先进的医疗保健系统、高度的认知度和有计划的报销政策促进了该地区的市场成长。然而,亚太地区预计在预测期内将大幅成长。
  • 该行业的一些主要企业包括:Advanced Brain Monitoring, Inc.;Cadwell Industries, Inc.;佳能医疗系统公司;Compumedics Ltd.;Magstim EGI;通用电气公司;日立有限公司;Koninklijke Philips NV;美敦力;Natus Medical Incorporated ;NeuroLogica Corp.

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 非侵入性脑外伤监测设备市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 非侵入性脑外伤监测设备市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 非侵入性脑外伤监测设备市场:产品估算及趋势分析

  • 细分仪表板
  • 非侵入性脑外伤监测设备市场:2023 年和 2030 年按产品分類的变化分析
  • 监控装置
  • 消耗品

第五章 非侵入性脑外伤监测设备市场:最终用途估计与趋势分析

  • 细分仪表板
  • 非侵入性脑外伤监测设备市场:2023 年和 2030 年最终用途的变化分析
  • 医院
  • 神经中枢
  • 其他的

第六章 非侵入性脑外伤监测设备市场:区域估计与趋势分析

  • 2023年及2030年非侵入性脑外伤监测设备按地区市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲(中东/非洲)
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Advanced Brain Monitoring, Inc.
    • Cadwell Industries, Inc.
    • Canon Medical Systems Corporations
    • Compumedics Ltd.
    • Magstim EGI
    • General Electric Company
    • Hitachi, Ltd.
    • Koninklijke Philips NV
    • Medtronic
    • Natus Medical Incorporated
    • NeuroLogica Corp.
    • NeuroWave Systems, Inc.
    • Nihon Kohden Corporation
    • Noraxon USA
    • RAUMEDIC AG
    • Sense Neuro
    • Siemens
    • Sophysa
    • Spiegelberg GmbH &Co. KG
简介目录
Product Code: GVR-1-68038-022-4

Non-invasive Brain Trauma Monitoring Devices Market Growth & Trends:

The global non-invasive brain trauma monitoring devices market size is expected to reach USD 24.8 billion by 2030, registering to grow at a CAGR of 8.6% from 2024 to 2030 according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer's and Parkinson's disease. As a result, there are numerous initiatives taken at the regional and global levels to create awareness, which facilitated a heavy diagnosis rate, thus governing the growth of non-invasive brain trauma monitoring devices.

Technological advancements in this field are connected with accuracy, portability, and affordability, which are supporting the industry growth. For instance, recently available non-invasive intracranial pressure monitors, such as Transcranial Doppler (TCD), are accurate in positioning and creating a better pressure gradient and also bringing in more accuracy in the treatment.

The Minimally Invasive Surgeries (MIS) are less traumatic to patients and facilitate faster recovery with minimum complications. In minimally invasive neurological surgeries, non-invasive brain trauma monitoring devices play a critical role. Thus, the increasing volume of MIS is driving the industry's growth.

The key target population in this industry includes people above 60 years. This section of the population is at a greater risk for TBIs and their co-morbidities. The global geriatric population is on arise and is a vital driver for this industry.

Non-invasive Brain Trauma Monitoring Devices Market Report Highlights:

  • Monitoring devices that include intracranial pressure monitors, MRI scanners, CT scanners, PET scanners, EEG, and MEG held a substantial share of around 63.2% in 2023. The high costs associated with this equipment and the increasing usage of these devices governed the growth of this segment.
  • The consumables sub-segment in the product segment is anticipated to witness lucrative growth over the forecast period. The repeat purchase of consumables and regular maintenance activities are expected to spur the demand for these products.
  • The market on the basis of end-use is segmented into hospitals, neurological centers, and other settings. The hospital segment dominated the end-use segment with over 80.9% of the revenue. The greater volume of surgeries performed in hospitals contributed to its growth.
  • North America dominated the non-invasive brain trauma monitoring devices market in 2023. The advanced healthcare system, high awareness level, and well-planned reimbursement policies helped this market to grow in this region. However, Asia Pacific is anticipated to witness significant growth over the forecast period.
  • Some key players operating in this industry include Advanced Brain Monitoring, Inc.; Cadwell Industries, Inc.; Canon Medical Systems Corporation; Compumedics Ltd.; Magstim EGI; General Electric Company; Hitachi, Ltd.; Koninklijke Philips N.V.; Medtronic; Natus Medical Incorporated; NeuroLogica Corp.; NeuroWave Systems, Inc., are the key initiatives in this industry.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Non-Invasive Brain Trauma Monitoring Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Non-Invasive Brain Trauma Monitoring Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Non-Invasive Brain Trauma Monitoring Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Non-Invasive Brain Trauma Monitoring Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Monitoring Devices
    • 4.3.1. Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Intra Cranial Pressure Monitor
      • 4.3.2.1. Intra Cranial Pressure Monitor Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. MRI Scanner
      • 4.3.3.1. MRI Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. CT Scanner
      • 4.3.4.1. CT Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. PET Scanner
      • 4.3.5.1. PET Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. EEG
      • 4.3.6.1. EEG Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.7. MEG
      • 4.3.7.1. MEG Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.8. Others
      • 4.3.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Electrodes
      • 4.4.2.1. Electrodes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Sensors
      • 4.4.3.1. Sensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Fibre Optic Cables
      • 4.4.4.1. Fibre Optic Cables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Non-Invasive Brain Trauma Monitoring Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Non-Invasive Brain Trauma Monitoring Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Neurological Centers
    • 5.4.1. Neurological Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Non-Invasive Brain Trauma Monitoring Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Non-Invasive Brain Trauma Monitoring Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East & Africa (MEA)
    • 6.6.1. MEA Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Advanced Brain Monitoring, Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Cadwell Industries, Inc.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. Canon Medical Systems Corporations
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Compumedics Ltd.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Magstim EGI
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. General Electric Company
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Hitachi, Ltd.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Koninklijke Philips N.V.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Medtronic
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Natus Medical Incorporated
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. NeuroLogica Corp.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. NeuroWave Systems, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives
    • 7.4.13. Nihon Kohden Corporation
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/Strategic Initiatives
    • 7.4.14. Noraxon USA
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/Strategic Initiatives
    • 7.4.15. RAUMEDIC AG
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/Strategic Initiatives
    • 7.4.16. Sense Neuro
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/Strategic Initiatives
    • 7.4.17. Siemens
      • 7.4.17.1. Participant's Overview
      • 7.4.17.2. Financial Performance
      • 7.4.17.3. Product Benchmarking
      • 7.4.17.4. Recent Developments/Strategic Initiatives
    • 7.4.18. Sophysa
      • 7.4.18.1. Participant's Overview
      • 7.4.18.2. Financial Performance
      • 7.4.18.3. Product Benchmarking
      • 7.4.18.4. Recent Developments/Strategic Initiatives
    • 7.4.19. Spiegelberg GmbH & Co. KG
      • 7.4.19.1. Participant's Overview
      • 7.4.19.2. Financial Performance
      • 7.4.19.3. Product Benchmarking
      • 7.4.19.4. Recent Developments/Strategic Initiatives